These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38620975)

  • 21. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
    Hanson BA; Visvabharathy L; Orban ZS; Jimenez M; Batra A; Liotta EM; DeLisle RK; Klausner JD; Cohen P; Padhye AS; Tachas G; Koralnik IJ
    Brain Behav Immun; 2023 Nov; 114():462-474. PubMed ID: 37704012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post COVID fatigue: Can we really ignore it?
    Sharma P; Bharti S; Garg I
    Indian J Tuberc; 2022 Apr; 69(2):238-241. PubMed ID: 35379408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Vernon SD; Funk S; Bateman L; Stoddard GJ; Hammer S; Sullivan K; Bell J; Abbaszadeh S; Lipkin WI; Komaroff AL
    Front Med (Lausanne); 2022; 9():917019. PubMed ID: 35847821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study.
    Hartung TJ; Neumann C; Bahmer T; Chaplinskaya-Sobol I; Endres M; Geritz J; Haeusler KG; Heuschmann PU; Hildesheim H; Hinz A; Hopff S; Horn A; Krawczak M; Krist L; Kudelka J; Lieb W; Maetzler C; Mehnert-Theuerkauf A; Montellano FA; Morbach C; Schmidt S; Schreiber S; Steigerwald F; Störk S; Maetzler W; Finke C
    EClinicalMedicine; 2022 Nov; 53():101651. PubMed ID: 36133318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment.
    Prato A; Salerno AM; Saia F; Maugeri N; Zanini A; Scerbo M; Barone R; Rizzo R
    BMC Pediatr; 2023 May; 23(1):222. PubMed ID: 37147589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delirium and Cognitive Impairment as Predisposing Factors of COVID-19 Infection in Neuropsychiatric Patients: A Narrative Review.
    Fabrazzo M; Russo A; Camerlengo A; Tucci C; Luciano M; De Santis V; Perris F; Catapano F; Coppola N
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised controlled trial testing the efficacy of Fit after COVID, a cognitive behavioural therapy targeting severe post-infectious fatigue following COVID-19 (ReCOVer): study protocol.
    Kuut TA; Müller F; Aldenkamp A; Assmann-Schuilwerve E; Braamse A; Geerlings SE; Gibney KB; Kanaan RAA; Nieuwkerk P; Olde Hartman TC; Pauëlsen D; Prins M; Slieker K; Van Vugt M; Bleeker-Rovers CP; Keijmel SP; Knoop H
    Trials; 2021 Dec; 22(1):867. PubMed ID: 34857010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.
    Augustin M; Schommers P; Stecher M; Dewald F; Gieselmann L; Gruell H; Horn C; Vanshylla K; Cristanziano VD; Osebold L; Roventa M; Riaz T; Tschernoster N; Altmueller J; Rose L; Salomon S; Priesner V; Luers JC; Albus C; Rosenkranz S; Gathof B; Fätkenheuer G; Hallek M; Klein F; Suárez I; Lehmann C
    Lancet Reg Health Eur; 2021 Jul; 6():100122. PubMed ID: 34027514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive Impairment and Risk Factors in Post-COVID-19 Hospitalized Patients.
    Khieukhajee J; Rojana-Udomsart A; Srisarakorn P; Wongsurit T; Aungsumart S
    Dement Geriatr Cogn Dis Extra; 2023; 13(1):18-27. PubMed ID: 37900719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prevalence of COVID-19 Fog and the Impact on Quality of Life After SARS-CoV-2 Infection (QoL-COVID): A Cross Sectional Study.
    Rego de Figueiredo I; Branco Ferrão J; Dias S; Drummond Borges D; Fernandes J; Bernardino V; Gruner H; Panarra A
    Acta Med Port; 2023 Oct; 36(10):631-638. PubMed ID: 36790319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatigue and Mental Illness Symptoms in Long COVID: Protocol for a Prospective Cohort Multicenter Observational Study.
    Pires L; Reis C; Mesquita Facão AR; Moniri A; Marreiros A; Drummond M; Berger-Estilita J
    JMIR Res Protoc; 2024 Jan; 13():e51820. PubMed ID: 38241071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of sleep disruption on cognitive function in patients with postacute sequelae of SARS-CoV-2 infection: initial findings from a Neuro-COVID-19 clinic.
    Reid KJ; Ingram LT; Jimenez M; Orban ZS; Abbott SM; Grimaldi D; Knutson KL; Zee PC; Koralnik IJ; Maas MB
    Sleep Adv; 2024; 5(1):zpae002. PubMed ID: 38370438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
    Carod-Artal FJ
    Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Network Perspective on Neuropsychiatric and Cognitive Symptoms of the Post-COVID Syndrome.
    Scharfenberg D; Schild AK; Warnke C; Maier F
    Eur J Psychol; 2022 Nov; 18(4):350-356. PubMed ID: 36605094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival.
    Stefano GB; Ptacek R; Ptackova H; Martin A; Kream RM
    Med Sci Monit; 2021 Jan; 27():e930886. PubMed ID: 33487628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms.
    Delgado-Alonso C; Díez-Cirarda M; Pagán J; Pérez-Izquierdo C; Oliver-Mas S; Fernández-Romero L; Martínez-Petit Á; Valles-Salgado M; Gil-Moreno MJ; Yus M; Matías-Guiu J; Ayala JL; Matias-Guiu JA
    Eur J Neurol; 2023 Oct; ():. PubMed ID: 37797297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients.
    Fleischer M; Szepanowski F; Tovar M; Herchert K; Dinse H; Schweda A; Mausberg AK; Holle-Lee D; Köhrmann M; Stögbauer J; Jokisch D; Jokisch M; Deuschl C; Skoda EM; Teufel M; Stettner M; Kleinschnitz C
    Neurol Ther; 2022 Dec; 11(4):1637-1657. PubMed ID: 36028604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Multidisciplinary Rehabilitation Enhanced with Neuropsychological Treatment on Post-Acute SARS-CoV-2 Cognitive Impairment (Brain Fog): An Observational Study.
    Rabaiotti P; Ciracì C; Donelli D; Oggioni C; Rizzi B; Savi F; Antonelli M; Rizzato M; Moderato L; Brambilla V; Ziveri V; Brambilla L; Bini M; Nouvenne A; Lazzeroni D
    Brain Sci; 2023 May; 13(5):. PubMed ID: 37239263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.